78 related articles for article (PubMed ID: 21933631)
1. Nerve growth factor expression in astrocytoma and cerebrospinal fluid: a new biomarker for prognosis of astrocytoma.
Li QY; Yang Y; Zhang Y; Zhang ZJ; Gong AH; Yuan ZC; Lu PS; Zhan LP; Wang P; Feng Y; Xu WL
Chin Med J (Engl); 2011 Jul; 124(14):2222-7. PubMed ID: 21933631
[TBL] [Abstract][Full Text] [Related]
2. Proteomics of tumor-specific proteins in cerebrospinal fluid of patients with astrocytoma: usefulness of gelsolin protein.
Ohnishi M; Matsumoto T; Nagashio R; Kageyama T; Utsuki S; Oka H; Okayasu I; Sato Y
Pathol Int; 2009 Nov; 59(11):797-803. PubMed ID: 19883430
[TBL] [Abstract][Full Text] [Related]
3. Expression of tenascin-C in various human brain tumors and its relevance for survival in patients with astrocytoma.
Leins A; Riva P; Lindstedt R; Davidoff MS; Mehraein P; Weis S
Cancer; 2003 Dec; 98(11):2430-9. PubMed ID: 14635078
[TBL] [Abstract][Full Text] [Related]
4. Nerve Growth Factor (NGF) up-regulation in the cerebrospinal fluid of newborns with myelomeningocele.
Chiaretti A; Massimi L; Ausili E; Capozzi D; Manni L; Di Rocco C; Paolucci V; Rendeli C
Eur Rev Med Pharmacol Sci; 2014; 18(6):894-9. PubMed ID: 24706316
[TBL] [Abstract][Full Text] [Related]
5. Expression of nuclear factor-kappaB in human astrocytomas: relation to pI kappa Ba, vascular endothelial growth factor, Cox-2, microvascular characteristics, and survival.
Korkolopoulou P; Levidou G; Saetta AA; El-Habr E; Eftichiadis C; Demenagas P; Thymara I; Xiromeritis K; Boviatsis E; Thomas-Tsagli E; Panayotidis I; Patsouris E
Hum Pathol; 2008 Aug; 39(8):1143-52. PubMed ID: 18495209
[TBL] [Abstract][Full Text] [Related]
6. MIB-1 labeling index in astrocytic tumors--a clinicopathologic study.
Neder L; Colli BO; Machado HR; Carlotti CG; Santos AC; Chimelli L
Clin Neuropathol; 2004; 23(6):262-70. PubMed ID: 15584210
[TBL] [Abstract][Full Text] [Related]
7. Geminin: a good prognostic factor in high-grade astrocytic brain tumors.
Shrestha P; Saito T; Hama S; Arifin MT; Kajiwara Y; Yamasaki F; Hidaka T; Sugiyama K; Kurisu K
Cancer; 2007 Mar; 109(5):949-56. PubMed ID: 17262828
[TBL] [Abstract][Full Text] [Related]
8. Expression and prognostic significance of survivin splice variants in diffusely infiltrating astrocytoma.
Huang Y; Chen X; Chen N; Nie L; Xu M; Zhou Q
J Clin Pathol; 2011 Nov; 64(11):953-9. PubMed ID: 21730264
[TBL] [Abstract][Full Text] [Related]
9. Grade-specific expression of insulin-like growth factor-binding proteins-2, -3, and -5 in astrocytomas: IGFBP-3 emerges as a strong predictor of survival in patients with newly diagnosed glioblastoma.
Santosh V; Arivazhagan A; Sreekanthreddy P; Srinivasan H; Thota B; Srividya MR; Vrinda M; Sridevi S; Shailaja BC; Samuel C; Prasanna KV; Thennarasu K; Balasubramaniam A; Chandramouli BA; Hegde AS; Somasundaram K; Kondaiah P; Rao MR
Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1399-408. PubMed ID: 20501753
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of a novel voltage gated potassium channel--Kv 1.5 in astrocytomas and its impact on prognosis in glioblastoma.
Arvind S; Arivazhagan A; Santosh V; Chandramouli BA
Br J Neurosurg; 2012 Feb; 26(1):16-20. PubMed ID: 21707241
[TBL] [Abstract][Full Text] [Related]
11. Nerve growth factor and doublecortin expression correlates with improved outcome in children with severe traumatic brain injury.
Chiaretti A; Antonelli A; Genovese O; Pezzotti P; Rocco CD; Viola L; Riccardi R
J Trauma; 2008 Jul; 65(1):80-5. PubMed ID: 18580535
[TBL] [Abstract][Full Text] [Related]
12. Elevated nerve growth factor levels in cerebrospinal fluid associated with progressive cortical atrophy.
Suzaki I; Hara T; Tanaka C; Dejima S; Takeshita K
Neuropediatrics; 1997 Oct; 28(5):268-71. PubMed ID: 9413006
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1.
Chambers SK; Kacinski BM; Ivins CM; Carcangiu ML
Clin Cancer Res; 1997 Jun; 3(6):999-1007. PubMed ID: 9815777
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of sphingosine kinase-1 expression in human astrocytomas progression and overall patient survival.
Li J; Guan HY; Gong LY; Song LB; Zhang N; Wu J; Yuan J; Zheng YJ; Huang ZS; Li M
Clin Cancer Res; 2008 Nov; 14(21):6996-7003. PubMed ID: 18980995
[TBL] [Abstract][Full Text] [Related]
15. Fas (Apo-1, CD95) receptor expression in childhood astrocytomas. Is it a marker of the major apoptotic pathway or a signaling receptor for immune escape of neoplastic cells?
Bodey B; Bodey B; Siegel SE; Kaiser HE
In Vivo; 1999; 13(4):357-73. PubMed ID: 10586378
[TBL] [Abstract][Full Text] [Related]
16. Relationship between CacyBP/SIP expression and prognosis in astrocytoma.
Zhao W; Wang C; Wang J; Ge A; Li Y; Li W; Lu Y
J Clin Neurosci; 2011 Sep; 18(9):1240-4. PubMed ID: 21764585
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of the RNA-binding motif protein 3 in human astrocytoma.
Zhang HT; Zhang ZW; Xue JH; Kong HB; Liu AJ; Li SC; Liu YX; Xu DG
Chin Med J (Engl); 2013; 126(10):1948-52. PubMed ID: 23673116
[TBL] [Abstract][Full Text] [Related]
18. The combination of low cytoplasmic and high nuclear expression of p27 predicts a better prognosis in high-grade astrocytoma.
Hidaka T; Hama S; Shrestha P; Saito T; Kajiwara Y; Yamasaki F; Sugiyama K; Kurisu K
Anticancer Res; 2009 Feb; 29(2):597-603. PubMed ID: 19331209
[TBL] [Abstract][Full Text] [Related]
19. Mucosal expression of nerve growth factor and brain-derived neurotrophic factor in chronic rhinosinusitis.
Coffey CS; Mulligan RM; Schlosser RJ
Am J Rhinol Allergy; 2009; 23(6):571-4. PubMed ID: 19958603
[TBL] [Abstract][Full Text] [Related]
20. [Endothelin-1 expression and quantitative analysis in astrocytomas].
Li JM; Wu XL; Zhu QJ; Wang QJ
Ai Zheng; 2002 Oct; 21(10):1109-11. PubMed ID: 12508654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
